Bio-Optronics and Synexus announce partnership to improve global research operations

Bio-Optronics, the creator of the market-leading Clinical Conductor Clinical Trial Management System (CTMS) announces a new partnership with Synexus, the world’s largest site network organization. This partnership is aimed at improving patient access to modern medicine and improving overall clinical trial efficiency by delivering high numbers of quality patients to clinical trials through the use of a unified CTMS across the entire Synexus network of more than 200 sites in eleven countries worldwide.

“This partnership combines the unique breadth and depth of the Synexus site network with the advanced collaborative trial management tools of Clinical Conductor CTMS in order to bring unparalleled quality, efficiency and profitability to global research operations,” says Max Elbaz, VP of Sales and Marketing at Bio-Optronics.

“As the largest site network in the world, our partnership with Bio-Optronics is important to our future growth. Rolling out Clinical Conductor across our whole organization is the only way we can consistently manage over 200 sites with hundreds of studies”, states Marcin Gondek, Chief Financial Officer at Synexus. “To us, Bio-Optronics are more than just a software vendor, they are a strategic partner who helps us find, manage and care for over 150,000 patients per year”

Both Synexus and Bio-Optronics are attending and sponsoring the 2018 EU Site Solutions Summit in London, England, March 26-27, 2018. Moving forward, Bio-Optronics and Synexus will continue to evolve how global clinical trials are managed across an expanding network of sites around the world.